A 2-Part, Open-Label, Randomized, Crossover Study to Evaluate the Bioequivalence of the 70-mg Alendronate/5600 IU Vitamin D3 Final Market Combination Tablet to a 70-mg Alendronate Marketed Tablet, and the Relative Bioavailability of Vitamin D3.
Phase of Trial: Phase I
Latest Information Update: 18 Nov 2016
At a glance
- Drugs Alendronic acid; Alendronic acid/colecalciferol; Colecalciferol
- Indications Osteoporosis
- Focus Pharmacokinetics
- Sponsors Merck & Co
- 10 Dec 2008 New trial record.